CareDx, Inc. (CDNA) vs Personalis, Inc. (PSNL)
- CareDx, Inc. CDNA 77.96 +2.14%
- Personalis, Inc. PSNL 15.70 +0.96%
CareDx, Inc. and Personalis, Inc. are both Diagnostics & Research companies. CareDx, Inc. is the larger, with a market value of $4.0B against $1.7B — 2.4× the size. Personalis, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 30.9×. CareDx, Inc. grew revenue faster over the last twelve months: 38.9% against 16.9%. CareDx, Inc. has the higher net margin (25.9% vs −147.7%) and the higher return on invested capital (33.6% vs −358.4%). Across the 17 metrics below, CareDx, Inc. leads on 13 and Personalis, Inc. on 4.
Valuation
Profitability
| Metric | CDNA | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.97% | 16.71% | 48.32% |
| Operating margin | 23.42% | (156.66%) | (5.68%) |
| Net margin | 25.86% | (147.74%) | (4.10%) |
| Free cash flow margin | 12.01% | (120.79%) | 0.00% |
| Return on equity | 33.04% | (62.14%) | 0.00% |
| Return on assets | 23.96% | (44.66%) | (6.05%) |
| Return on invested capital | 33.56% | (358.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack